| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/25/2014 | US8658673 BETA2-adrenoreceptor agonists |
| 02/25/2014 | US8658648 Modified chloroquines with single ring moiety or fused ring moiety |
| 02/25/2014 | US8658636 TRPV4 antagonists |
| 02/25/2014 | CA2207252C Inhibitors of prenyl transferases |
| 02/22/2014 | CA2787472A1 Protein kinase inhibitors |
| 02/20/2014 | US20140051854 Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof |
| 02/20/2014 | US20140051852 Process for Synthesizing Oxidized Lactam Compounds |
| 02/20/2014 | US20140051724 Modulators of atp-binding cassette transporters |
| 02/20/2014 | US20140051723 Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof |
| 02/19/2014 | EP2697213A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 02/19/2014 | EP2697201A2 N-ethyl-4-hydroxyl-1-methyl-5-(methyl(2,3,4,5,6-pentahydroxyhexyl) amino)-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide |
| 02/19/2014 | EP2697200A1 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators |
| 02/19/2014 | CN103596927A Novel process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline |
| 02/19/2014 | CN103588660A Novel acyl aniline compound and application thereof |
| 02/19/2014 | CN103588649A Method for synthesizing arylamine methylacetylene |
| 02/19/2014 | CN102633718B Preparation method of high-purity cinchocaine hydrochloride |
| 02/19/2014 | CN102558046B Solid-phase synthesis method of quinoline compound |
| 02/18/2014 | US8653263 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators |
| 02/18/2014 | US8653105 Quinoline derivatives as kinase inhibitors |
| 02/18/2014 | US8653102 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators |
| 02/18/2014 | US8653101 Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators |
| 02/18/2014 | US8653099 Cold menthol receptor antagonists |
| 02/18/2014 | US8653071 α4β2 neuronal nicotinic acetylcholine receptor ligands |
| 02/13/2014 | US20140045888 Compounds having antiparasitic or anti-infectious activity |
| 02/13/2014 | US20140045793 Quinolone compound and pharmaceutical composition |
| 02/12/2014 | EP2694480A1 Adamantyl compounds |
| 02/12/2014 | EP2694479A1 Process for the preparation of an hiv integrase inhibitor |
| 02/12/2014 | CN103570742A Condensation compound and organic light emitting device including same |
| 02/12/2014 | CN103570619A Preparation method of montelukast sodium derivative |
| 02/12/2014 | CN103570618A Preparation method of montelukast sodium |
| 02/12/2014 | CN102617462B Specificity inhibition muscle micro ribonucleic acid compound and synthesis method and application thereof |
| 02/11/2014 | US8648196 Preparation of pyridonecarboxylic acid antibacterials |
| 02/11/2014 | US8648195 Stabilized crystal of 2-ethyl-3,7-dimethyl-6-(4-(trifluoromethoxy)phenoxy)quinoline-4-yl methyl carbonate, process for producing the crystal, and agricultural chemical composition comprising the crystal |
| 02/11/2014 | US8648093 Salt and crystalline forms thereof of a drug |
| 02/11/2014 | US8647646 Crystals of laquinimod sodium, and process for the manufacture thereof |
| 02/11/2014 | CA2685215C Compounds and methods useful for treating asthma and allergic inflammation |
| 02/06/2014 | WO2014022707A1 Process and intermediates for preparing integrase inhibitors |
| 02/06/2014 | WO2014021281A1 Partially saturated nitrogen-containing heterocyclic compound |
| 02/06/2014 | WO2013012199A8 Capsule formulation comprising montelukast and levocetirizine |
| 02/06/2014 | US20140039194 Process and intermediates for preparing integrase inhibitors |
| 02/06/2014 | US20140039006 Tetrahydroquinoline Derivatives Useful As Bromodomain Inhibitors |
| 02/06/2014 | US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/06/2014 | US20140038962 Flavivirus Inhibitors and Methods of Their Use |
| 02/06/2014 | US20140038951 Pde10 inhibitors and related compositions and methods |
| 02/06/2014 | US20140038948 Compounds and methods for kinase modulation, and indications therefor |
| 02/06/2014 | US20140038883 Novel azacoumarin derivatives having mdr pump inhibiting activity |
| 02/05/2014 | EP2691372A1 Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents |
| 02/05/2014 | CN103555319A Fluorine-containing cyproquinoline Schiff base blue luminescent material and preparation method thereof |
| 02/05/2014 | CN103554020A Novel method for synthesizing quinoline derivative from alkyne and imine |
| 02/05/2014 | CN103554019A Synthetic method of tilbroquinol |
| 02/05/2014 | CN103554018A Dihydroquinolone alkaloid compound as well as crystal, preparation method and application thereof as marine anti-fouling agent |
| 02/05/2014 | CN103554017A Preparation method of montelukast chiral intermediate |
| 02/05/2014 | CN103554016A Processing technology of non-hormonal anti-inflammatory drug intermediate |
| 02/05/2014 | CN103554011A Anthracene containing derivative as well as preparation method and application thereof |
| 02/05/2014 | CN103550945A Distilling apparatus used in production process of rubber aging inhibitor tetramethylhydroquinone (TMQ) |
| 02/04/2014 | US8642767 Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof |
| 02/04/2014 | US8642760 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/04/2014 | US8642619 Quinolone compound and pharmaceutical composition |
| 02/04/2014 | US8642598 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 01/30/2014 | US20140031545 Organozinc complexes and processes for making and using the same |
| 01/30/2014 | US20140031391 Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use |
| 01/30/2014 | US20140031388 Akt inactivation by tocopheryl derivatives |
| 01/30/2014 | US20140031370 Amide derivatives, process for preparation thereof and use thereof as insecticide |
| 01/30/2014 | US20140031368 Selective hdac inhibitors |
| 01/30/2014 | US20140031363 NMDA Receptor Antagonists for Neuroprotection |
| 01/30/2014 | US20140031338 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 01/30/2014 | US20140031336 Tetrahydroquinoline Derivatives Useful As Bromodomain Inhibitors |
| 01/30/2014 | US20140030523 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/29/2014 | CN103539734A Preparation method of 3-allyl quinoline |
| 01/29/2014 | CN103539726A Novel compound with electron injection and/or electron transport capabilities and organic light-emitting device including the same |
| 01/29/2014 | CN103539631A Photochemical synthesis method for preparing chloroaromatics compound through halogen conversion reaction |
| 01/29/2014 | CN103539596A Method for catalyzing transfer of hydrogen controllable reduction nitro-compound in formic acid or formate |
| 01/29/2014 | CN102816114B Preparation method of HMG-CoA reductase inhibitor |
| 01/29/2014 | CN101654435B N-benzyl quinoline carboxylic acid compound, combination and preparation method thereof |
| 01/28/2014 | US8637543 Quinoline derivatives as kinase inhibitors |
| 01/28/2014 | CA2609659C Azanaphthalenes, compositions and methods for treating retinal disease |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/23/2014 | WO2014012889A1 Anti-angiogenic compounds |
| 01/23/2014 | US20140024665 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/23/2014 | US20140024608 Inhibitors of histone deacetylase and prodrugs thereof |
| 01/22/2014 | EP2687512A1 Crystals of Laquinimod Sodium, and Process for the Manufacture Thereof |
| 01/22/2014 | EP2686301A1 Montelukast intermediate camphorsulfonic salt |
| 01/22/2014 | CN103534238A Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents |
| 01/22/2014 | CN103524448A Enrofloxacin-saccharin compound |
| 01/22/2014 | CN103524411A Synthetic method of 5-cholro-8-quinoline oxyacetic acid |
| 01/22/2014 | CN103524410A 4-quinolone-N-carboxylic acid molecular crystal, and preparation method and application thereof |
| 01/22/2014 | CN103524409A Quinoline compound as well as preparation method and application thereof |
| 01/22/2014 | CN103524408A Method for preparing 7-chloroquinaldine by use of phase-transfer catalytic reaction |
| 01/22/2014 | CN102167664B Fluorine-containing rare earth salt and applications thereof |
| 01/21/2014 | US8633320 Process for preparing bromo-substituted quinolines |
| 01/21/2014 | US8633235 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 01/21/2014 | US8633220 Therapeutic agents for ocular hypertension |
| 01/21/2014 | US8633196 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/21/2014 | US8633182 Indanyloxyphenylcyclopropanecarboxylic acids |
| 01/21/2014 | CA2622000C Quinolines and their therapeutic use |
| 01/16/2014 | WO2014009891A1 Heterocyclic compounds for use in the treatment of cancers |
| 01/16/2014 | WO2014008640A1 Indacaterol intermediate and method for synthesizing indacaterol |
| 01/16/2014 | WO2014008639A1 Method for preparing indacaterol |
| 01/16/2014 | US20140018388 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/16/2014 | US20140018384 Quinolinone derivatives for use in the treatment of an autoimmune disease and/or an inflammatory disease |